Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996

Conditions
B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • TG Therapeutics Investigational Trial Site Heidelberg, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Melbourne, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Nedlands, Western Australia, Australia
View Trial Details
Completed

Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

NCT04554485

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University Hospital Brno, Internal hematology and oncology clinic Brno, Czechia
  • University Hospital Hradec Kralove,The 4th Department of Internal Medicine - Hematology Hradec Králové, Czechia
  • University Hospital Olomouc, Hematooncology Clinic Olomouc, Czechia
  • University Hospital Ostrava, Hematooncology Clinic Ostrava, Czechia
View Trial Details
Completed

Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas

NCT02341014

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies

NCT03310619

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Local Institution - 011 Duarte, California, United States
  • Local Institution - 022 Atlanta, Georgia, United States
  • Local Institution - 014 Chicago, Illinois, United States
  • Local Institution - 012 Boston, Massachusetts, United States
View Trial Details
Completed

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

NCT03959241

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 39 locations
View Trial Details
Completed

NPO Before Sedation

NCT05810532

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Kangbuk Samsung Hospital Seoul, South Korea
View Trial Details

Related conditions